GOLDMAN SACHS GROUP INC - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 96 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$70,000
-45.3%
64,273
-37.2%
0.00%
Q1 2022$128,000
-69.2%
102,321
-60.6%
0.00%
Q4 2021$416,000
-38.5%
259,856
+25.2%
0.00%
Q3 2021$676,000
+113.9%
207,569
+315.1%
0.00%
Q2 2021$316,000
+134.1%
50,007
-21.6%
0.00%
Q1 2021$135,000
+159.6%
63,770
+199.3%
0.00%
Q3 2020$52,00021,3040.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 347,392$2560.02%
XTX Topco Ltd 167,427$123,3100.02%
Laurion Capital Management LP 2,225,800$1,639,3020.01%
Virtu Financial LLC 80,728$590.01%
Renaissance Technologies 1,242,370$9150.00%
LVM CAPITAL MANAGEMENT LTD/MI 21,000$150.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,8250.00%
Connor, Clark & Lunn Investment Management Ltd. 133,591$98,3900.00%
Caption Management, LLC 75,000$55,2380.00%
J. L. Bainbridge & Co., Inc. 11,121$8,1910.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders